Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European Union

Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European Union

TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corpo…

Next-generation tau radiotracers outperform FDA-approved imaging agents in detecting Alzheimer's disease

Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for detecting tau tangles in the brain, a hallmark of Alzheimer's disease. In a head-to-head comparison of the three imaging agents, the next-generation radiotracers exhibited higher binding to Alzheimer's disease brain tissue and a greater selectivity for identifying the tangles. This research, which was published in the January i…

New imaging method could detect Alzheimer’s disease effectively

Scientists have developed two new imaging agents that work better than the only currently approved one for detecting tau tangles in the brain. Tau tangles are abnormal protein clumps linked to Alzheimer’s disease, a condition that causes memory loss and cognitive decline. The study, published in The Journal of Nuclear Medicine, compared these new agents with […] The post New imaging method could detect Alzheimer’s disease effectively appeared fi…

Alzheimer's disease: New radiotracers for better detection

Two new PET radiotracers have outperformed the only currently Food and Drug Administration (FDA) approved radiotracer for detecting tau tangles in the brain, a hallmark of Alzheimer’s disease.

New Guidance for Amyloid and Tau PET Imaging Released

New guidance guides primary care physicians, neurologists, and other physicians on appropriate use of amyloid and tau imaging in the diagnosis and management of patients with cognitive decline.

Amsterdam – The road to approval of the first causal Alzheimer's therapy in the European Union is rockier than expected. At the request of the European Commission, the Committee for Medicinal Products for Human Use (CHMP), which is part of the European...